Julius Asubonteng

Regeneron Pharmaceuticals, Inc., United States

Disclosure information not submitted.

Presentation(s):

• 2D-03 - Mind the gap: a simulation study to compare definitions of treatment discontinuation

  Sunday, August 24, 2025
  3:40 PM - 3:45 PM ET

• 4E-04 - Bigger is better: replicating a signal detection study using tree-based scan statistics in two real world data sources

  Monday, August 25, 2025
  5:00 PM - 5:15 PM ET

• 6F-01 - One Disease, Three Definitions: Unpacking the Impact of Cohort Entry Date Choice on Type 2 Diabetes Identification Using Claims

  Tuesday, August 26, 2025
  1:30 PM - 1:45 PM ET